Engineering the immune system to ascend beyond cancer & autoimmune disease
Ascendra Therapeutics is developing off-the-shelf plasmid DNA and personalized mRNA vaccines that train the body to recognize and eliminate disease.
Explore Ascendra
Who we are and what we're building
About
A privately held, clinical-stage biopharmaceutical company headquartered in San Francisco.
Learn more →Platform
Off-the-shelf plasmid DNA and personalized mRNA vaccines, and how they train the immune system.
Learn more →Pipeline
Investigational programs in gastric, breast and ovarian cancer, plus autoimmune disease.
Learn more →Team
Seasoned drug developers, oncologists and immunologists leading the company.
Learn more →Get in touch
For scientific, clinical, media or general questions, please reach out using the form and a member of our team will respond.